After Lilly accord, Organon's CEO is hungry to ink more deals fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.
Full year 2023 revenue of $6.3 billion, up 1% as-reported and 3% at constant currency
Full year 2023 diluted earnings per share of $3.99 and non-GAAP Adjusted diluted earnings per share of.
FE Exclusive | We will be launching JADA System to combat postpartum hemorrhage in India later this year: Andreas Daugaard, MD, SEA Cluster at Organon financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.
14.09.2023 - Organon (NYSE: OGN), a global healthcare company focused on improving women’s health, today announced that Obstetrics & Gynecology (“The Green Journal”), the peer-reviewed journal of the American College of Obstetrics and Gynecology (ACOG), .